83 FR 54610 - Importer of Controlled Substances Application: Cambrex High Point, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 83, Issue 210 (October 30, 2018)

Page Range		54610-54610
FR Document		2018-23699

Federal Register, Volume 83 Issue 210 (Tuesday, October 30, 2018)

[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Page 54610]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-23699]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Cambrex High 
Point, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before November 29, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before November 29, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    The Attorney General has delegated his authority under the 
Controlled Substances Act to the Administrator of the Drug Enforcement 
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all 
necessary functions with respect to the promulgation and implementation 
of 21 CFR part 1301, incident to the registration of manufacturers, 
distributors, dispensers, importers, and exporters of controlled 
substances (other than final orders in connection with suspension, 
denial, or revocation of registration) has been redelegated to the 
Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on July 
16, 2018, Cambrex High Point, Inc., 4180 Mendenhall Oaks Parkway, High 
Point, North Carolina 27265-8017 applied to be registered as an 
importer of the following basic class of controlled substance:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Poppy Straw Concentrate..............        9670  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance for 
clinical trial narcotic material for bulk manufacture.

     Dated: October 22, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-23699 Filed 10-29-18; 8:45 am]
 BILLING CODE 4410-09-P

54610 Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices

Commission is properly sought will be DATES: Registered bulk manufacturers of 2018, Cambrex High Point, Inc., 4180
treated accordingly. All information, the affected basic classes, and Mendenhall Oaks Parkway, High Point,
including confidential business applicants therefore, may file written North Carolina 27265–8017 applied to
information and documents for which comments on or objections to the be registered as an importer of the
confidential treatment is properly issuance of the proposed registration on following basic class of controlled
sought, submitted to the Commission for or before November 29, 2018. Such substance:
purposes of this Investigation may be persons may also file a written request
disclosed to and used: (i) By the for a hearing on the application on or Controlled Drug code Schedule
Commission, its employees and Offices, before November 29, 2018. substance
and contract personnel (a) for ADDRESSES: Written comments should Poppy Straw Con- 9670 II
developing or maintaining the records be sent to: Drug Enforcement centrate.
of this or a related proceeding, or (b) in Administration, Attention: DEA Federal
internal investigations, audits, reviews, Register Representative/DPW, 8701 The company plans to import the
and evaluations relating to the Morrissette Drive, Springfield, Virginia listed controlled substance for clinical
programs, personnel, and operations of 22152. All requests for hearing must be trial narcotic material for bulk
the Commission including under 5 sent to: Drug Enforcement manufacture.
U.S.C. Appendix 3; or (ii) by U.S. Administration, Attn: Administrator,
Dated: October 22, 2018.
government employees and contract 8701 Morrissette Drive, Springfield,
personnel,1 solely for cybersecurity Virginia 22152. All requests for hearing John J. Martin,
purposes. All nonconfidential written should also be sent to: (1) Drug Assistant Administrator.
submissions will be available for public Enforcement Administration, Attn: [FR Doc. 2018–23699 Filed 10–29–18; 8:45 am]
inspection at the Office of the Secretary Hearing Clerk/OALJ, 8701 Morrissette BILLING CODE 4410–09–P
and on EDIS. Drive, Springfield, Virginia 22152; and
The authority for the Commission’s (2) Drug Enforcement Administration,
determination is contained in section Attn: DEA Federal Register DEPARTMENT OF JUSTICE
337 of the Tariff Act of 1930, as Representative/DPW, 8701 Morrissette
amended (19 U.S.C. 1337), and in part Drug Enforcement Administration
Drive, Springfield, Virginia 22152.
210 of the Commission’s Rules of SUPPLEMENTARY INFORMATION: [Docket No. DEA–392]
Practice and Procedure (19 CFR part The Attorney General has delegated
210). his authority under the Controlled Importer of Controlled Substances
By order of the Commission. Substances Act to the Administrator of Registration
Issued: October 24, 2018. the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to ACTION: Notice of registration.
Jessica Mullan,
exercise all necessary functions with
Attorney Advisor. SUMMARY: The registrant listed below
respect to the promulgation and
[FR Doc. 2018–23618 Filed 10–29–18; 8:45 am] has applied for and been granted
implementation of 21 CFR part 1301,
registration by the Drug Enforcement
BILLING CODE 7020–02–P incident to the registration of
Administration (DEA) as an importer of
manufacturers, distributors, dispensers,
schedule I or schedule II controlled
importers, and exporters of controlled
substances.
DEPARTMENT OF JUSTICE substances (other than final orders in
connection with suspension, denial, or SUPPLEMENTARY INFORMATION:
Drug Enforcement Administration revocation of registration) has been The company listed below applied to
redelegated to the Assistant be registered as an importer of various
[Docket No. DEA–392] Administrator of the DEA Diversion basic classes of controlled substances.
Control Division (‘‘Assistant Information on the previously published
Importer of Controlled Substances Administrator’’) pursuant to section 7 of notice is listed in the table below. No
Application: Cambrex High Point, Inc. 28 CFR part 0, appendix to subpart R. comments or objections were submitted
In accordance with 21 CFR and no requests for hearing were
ACTION: Notice of application.
1301.34(a), this is notice that on July 16, submitted for this notice.

Company FR Docket Published

Cody Laboratories, Inc. ........................................................................................................................................ 83 FR 37524 August 1, 2018.

The DEA has considered the factors in treaties, conventions, or protocols in local laws, and reviewing the company’s
21 U.S.C. 823, 952(a) and 958(a) and effect on May 1, 1971. The DEA background and history.
determined that the registration of the investigated the company’s maintenance Therefore, pursuant to 21 U.S.C.
listed registrant to import the applicable of effective controls against diversion by 952(a) and 958(a), and in accordance
khammond on DSK30JT082PROD with NOTICES

basic classes of schedule I or II inspecting and testing the company’s with 21 CFR 1301.34, the DEA has
controlled substances is consistent with physical security systems, verifying the granted a registration as an importer for
the public interest and with United company’s compliance with state and schedule II controlled substances to the
States obligations under international above listed company.

1 All contract personnel will sign appropriate

nondisclosure agreements.

VerDate Sep<11>2014 17:34 Oct 29, 2018 Jkt 247001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\30OCN1.SGM 30OCN1

Document Created: 2018-10-30 00:43:33
Document Modified: 2018-10-30 00:43:33

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of application.
Dates		Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 29, 2018. Such persons may also file a written request for a hearing on the application on or before November 29, 2018.
FR Citation		83 FR 54610

83 FR 54610 - Importer of Controlled Substances Application: Cambrex High Point, Inc.

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 83, Issue 210 (October 30, 2018)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration